PRIMARY TRACK: Guideline development SECONDARY TRACK: Patient/family/stakeholder roles in guideline development BACKGROUND (INTRODUCTION): Key questions and recommendations in evidence-based guidelines should not only be based upon the current medical knowledge but should also respect patients' needs and preferences. Patient involvement in clinical guidelines guarantees the consideration of their points of view. It also is regarded as a quality criterion for evidence-based clinical guidelines according to AGREE and to the German instrument for guideline assessment (DELBI).
LEARNING OBJECTIVES (TRAINING GOALS):
1. Understand to which extent patient involvement is practiced in Germany. 2. Assess methods and different types of patient involvement in Germany.
METHODS:
The actual evidence-based guidelines in Germany which are relevant for ambulatory care have been assessed relating to consideration and appraisal of patient needs. In cases of direct or indirect patient involvement, we checked whether it was done according to a defined methodology. RESULTS: 121 evidence-based guidelines have been assessed. 31 of them had directly involved patients into the development process; in 9 guidelines they had been involved indirectly by peer review or consultation. 81 had been developed without patient representatives. Information on how pa-tients had been nominated was available in 22 guidelines. A defined methodology of patient or public involvement was documented only in 6 guidelines, 5 of them being part of the German National Disease Management Guidelines Program.
(Updated results will be presented in August 2010.) DISCUSSION (CONCLUSION): Patients have been involved in the guideline development process in less than 35%. In less than 5% patient involvement followed a defined methodology. Being an important implementation tool, patient involvement should become a standard in guideline development. In terms of transparency, nomination and involvement of patient representatives should be based upon a defined methodology. In Germany, a methodology for patient involvement is found only within national programs. Adaptation of this methodology by other guideline developers and cooperation with medical societies may enhance patient involvement. A clinical practice guideline should take into account patient perspective of the disease concerned. However, questions arise about qualitative research and suitability of patient participation, when and how it should be done, and its impact on the guideline. We are working within a national program in order to answer these questions. The purpose is to present our experience of taking into consideration patient views and preferences in the development of CPGs to help other guideline groups achieve an effective methodology.
LEARNING OBJECTIVES (TRAINING GOALS):
1. Identify methods to take into account patient views and preferences in the development of CPGs.
Show how qualitative research can be done to develop a
high-quality CPG. METHODS: Primary qualitative research was developed to identify issues relevant to patients by means of focus groups and in-depth interviews conducted with the patients. As for the health professionals, in-depth interviews and 'participant observation' techniques were used. Also, patients and patients' representatives participated in the development process. Sec-
